Cancer Cell International-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2253179, encodeId=34e422531e9d0, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：2024年5月投稿，7月一审返回，二审一直找不到人，中间发了几封催稿信，到2025年1月二审返回，但杂志社始终没做决定，等了一个月又发了信件询问，第一个审稿人没有意见，建议发表，第二个审稿人表示需要加一些实验，编辑给了rejection，历时10个月，中间除了写信询问，完全不知道进度如何，建议比较急的谨慎投稿，还有长时间没消息的也最好撤稿，要不然很大概率白费几个月的时间。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91bb9295575, createdName=ms7000000026116265, createdTime=Sun Feb 23 16:28:33 CST 2025, time=2025-02-23, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2252747, encodeId=7a782252e47b1, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：投稿过程还算顺利，等待送外审稿等了一个月，供参考： Submission received 18 Dec 2024 With editor 18 Dec 2024 First reviewer(s) invited 16 Jan 2025 Reviewer report(s) received 19 Jan 2025 Revision requested 21 Jan 2025 Revision received 29 Jan 2025 First reviewer(s) invited 31 Jan 2025 Reviewer report(s) received 07 Feb 2025 Submission accepted 13 Feb 2025, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=458e5258059, createdName=147f7447m93(暂无昵称), createdTime=Thu Feb 20 07:33:20 CST 2025, time=2025-02-20, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2232130, encodeId=3a1b22321306b, content=偏重的研究方向：肿瘤 经验分享：2024-03-19投稿 审稿意见已经显示返回，但就是不给反馈 这个杂志是最近是没人吗，编辑在干嘛啊啊，为什么这么慢，催稿邮件也不回复，想撤稿了。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d1875244065, createdName=147c8c2bm20(暂无昵称), createdTime=Mon Oct 21 14:02:34 CST 2024, time=2024-10-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2248365, encodeId=43642248365e4, content=审稿速度:4.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;生信 经验分享：5月投稿，7月with editor，期间一直邀请审稿人，11月两个审稿人接受邀请，12月审稿人提交意见，次日编辑给大修，给了14天，大修后3天接受。整体历时7个月，除了审稿人比较难找，编辑还是很有效率的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66e26515767, createdName=ms2000000771050051, createdTime=Thu Jan 16 17:59:37 CST 2025, time=2025-01-16, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2245126, encodeId=ad0b2245126e8, content=审稿速度:12.0 | 投稿命中率:75.0 经验分享：8个月了，还卡在第二个审稿人，我真是醉了。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91bb9295575, createdName=ms7000000026116265, createdTime=Fri Dec 27 10:42:00 CST 2024, time=2024-12-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2246927, encodeId=69b4224692e1d, content=妈的，2024年10月6号投的，到现在还是一直卡在审稿人邀请阶段，发了很多封咨询和催稿邮件都没得到任何回复，这个期刊究竟是怎么回事啊？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aeac6475076, createdName=ms1000000763838070, createdTime=Tue Jan 07 11:44:44 CST 2025, time=2025-01-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2242831, encodeId=4166224283167, content=偏重的研究方向：肿瘤;细胞生物学;生信 经验分享：With Editor2周了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65ab5425857, createdName=Doctorfan, createdTime=Mon Dec 16 10:52:12 CST 2024, time=2024-12-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2242971, encodeId=501e22429e1fe, content=为什么我的Research Square 那里这个杂志显示的是Draft呢?Research Square 里我投的其他杂志的文章标志都是Article, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1568789293, createdName=ms5000002019242226, createdTime=Mon Dec 16 19:32:14 CST 2024, time=2024-12-16, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2235847, encodeId=ccd9223584e59, content=偏重的研究方向：肿瘤;细胞生物学;Cancer 经验分享：发了邮件撤稿，都一周了编辑怎么还是不回复啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3868200180, createdName=ms1000001069261709, createdTime=Fri Nov 08 10:41:22 CST 2024, time=2024-11-08, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2207053, encodeId=7503220e05397, content=半年了，一点动静都没有，发邮件过去也没回复，什么情况啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEIX9OxibS9MeEepshV6P2nFfBwFyvFgJ2lrXAv18E1SwUCk5sZT1ZNfxwiaFCicIh4icVxLxez1qcWm0g/132, createdBy=fa5e2504185, createdName=ms8092613637533610, createdTime=Tue May 28 17:23:36 CST 2024, time=2024-05-28, status=1, ipAttribution=湖南省)]

2025-02-23 ms7000000026116265 来自上海

审稿速度:12.0 | 投稿命中率:50.0
经验分享：2024年5月投稿，7月一审返回，二审一直找不到人，中间发了几封催稿信，到2025年1月二审返回，但杂志社始终没做决定，等了一个月又发了信件询问，第一个审稿人没有意见，建议发表，第二个审稿人表示需要加一些实验，编辑给了rejection，历时10个月，中间除了写信询问，完全不知道进度如何，建议比较急的谨慎投稿，还有长时间没消息的也最好撤稿，要不然很大概率白费几个月的时间。。。。。

35 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2253179, encodeId=34e422531e9d0, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：2024年5月投稿，7月一审返回，二审一直找不到人，中间发了几封催稿信，到2025年1月二审返回，但杂志社始终没做决定，等了一个月又发了信件询问，第一个审稿人没有意见，建议发表，第二个审稿人表示需要加一些实验，编辑给了rejection，历时10个月，中间除了写信询问，完全不知道进度如何，建议比较急的谨慎投稿，还有长时间没消息的也最好撤稿，要不然很大概率白费几个月的时间。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91bb9295575, createdName=ms7000000026116265, createdTime=Sun Feb 23 16:28:33 CST 2025, time=2025-02-23, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2252747, encodeId=7a782252e47b1, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：投稿过程还算顺利，等待送外审稿等了一个月，供参考： Submission received 18 Dec 2024 With editor 18 Dec 2024 First reviewer(s) invited 16 Jan 2025 Reviewer report(s) received 19 Jan 2025 Revision requested 21 Jan 2025 Revision received 29 Jan 2025 First reviewer(s) invited 31 Jan 2025 Reviewer report(s) received 07 Feb 2025 Submission accepted 13 Feb 2025, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=458e5258059, createdName=147f7447m93(暂无昵称), createdTime=Thu Feb 20 07:33:20 CST 2025, time=2025-02-20, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2232130, encodeId=3a1b22321306b, content=偏重的研究方向：肿瘤 经验分享：2024-03-19投稿 审稿意见已经显示返回，但就是不给反馈 这个杂志是最近是没人吗，编辑在干嘛啊啊，为什么这么慢，催稿邮件也不回复，想撤稿了。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d1875244065, createdName=147c8c2bm20(暂无昵称), createdTime=Mon Oct 21 14:02:34 CST 2024, time=2024-10-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2248365, encodeId=43642248365e4, content=审稿速度:4.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;生信 经验分享：5月投稿，7月with editor，期间一直邀请审稿人，11月两个审稿人接受邀请，12月审稿人提交意见，次日编辑给大修，给了14天，大修后3天接受。整体历时7个月，除了审稿人比较难找，编辑还是很有效率的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66e26515767, createdName=ms2000000771050051, createdTime=Thu Jan 16 17:59:37 CST 2025, time=2025-01-16, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2245126, encodeId=ad0b2245126e8, content=审稿速度:12.0 | 投稿命中率:75.0 经验分享：8个月了，还卡在第二个审稿人，我真是醉了。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91bb9295575, createdName=ms7000000026116265, createdTime=Fri Dec 27 10:42:00 CST 2024, time=2024-12-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2246927, encodeId=69b4224692e1d, content=妈的，2024年10月6号投的，到现在还是一直卡在审稿人邀请阶段，发了很多封咨询和催稿邮件都没得到任何回复，这个期刊究竟是怎么回事啊？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aeac6475076, createdName=ms1000000763838070, createdTime=Tue Jan 07 11:44:44 CST 2025, time=2025-01-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2242831, encodeId=4166224283167, content=偏重的研究方向：肿瘤;细胞生物学;生信 经验分享：With Editor2周了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65ab5425857, createdName=Doctorfan, createdTime=Mon Dec 16 10:52:12 CST 2024, time=2024-12-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2242971, encodeId=501e22429e1fe, content=为什么我的Research Square 那里这个杂志显示的是Draft呢?Research Square 里我投的其他杂志的文章标志都是Article, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1568789293, createdName=ms5000002019242226, createdTime=Mon Dec 16 19:32:14 CST 2024, time=2024-12-16, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2235847, encodeId=ccd9223584e59, content=偏重的研究方向：肿瘤;细胞生物学;Cancer 经验分享：发了邮件撤稿，都一周了编辑怎么还是不回复啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3868200180, createdName=ms1000001069261709, createdTime=Fri Nov 08 10:41:22 CST 2024, time=2024-11-08, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2207053, encodeId=7503220e05397, content=半年了，一点动静都没有，发邮件过去也没回复，什么情况啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEIX9OxibS9MeEepshV6P2nFfBwFyvFgJ2lrXAv18E1SwUCk5sZT1ZNfxwiaFCicIh4icVxLxez1qcWm0g/132, createdBy=fa5e2504185, createdName=ms8092613637533610, createdTime=Tue May 28 17:23:36 CST 2024, time=2024-05-28, status=1, ipAttribution=湖南省)]

2025-02-20 147f7447m93(暂无昵称) 来自浙江省

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：肿瘤
经验分享：投稿过程还算顺利，等待送外审稿等了一个月，供参考： Submission received 18 Dec 2024 With editor 18 Dec 2024 First reviewer(s) invited 16 Jan 2025 Reviewer report(s) received 19 Jan 2025 Revision requested 21 Jan 2025 Revision received 29 Jan 2025 First reviewer(s) invited 31 Jan 2025 Reviewer report(s) received 07 Feb 2025 Submission accepted 13 Feb 2025

13 0

[GetPortalCommentsPageByObjectIdResponse(id=2253179, encodeId=34e422531e9d0, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：2024年5月投稿，7月一审返回，二审一直找不到人，中间发了几封催稿信，到2025年1月二审返回，但杂志社始终没做决定，等了一个月又发了信件询问，第一个审稿人没有意见，建议发表，第二个审稿人表示需要加一些实验，编辑给了rejection，历时10个月，中间除了写信询问，完全不知道进度如何，建议比较急的谨慎投稿，还有长时间没消息的也最好撤稿，要不然很大概率白费几个月的时间。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91bb9295575, createdName=ms7000000026116265, createdTime=Sun Feb 23 16:28:33 CST 2025, time=2025-02-23, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2252747, encodeId=7a782252e47b1, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：投稿过程还算顺利，等待送外审稿等了一个月，供参考： Submission received 18 Dec 2024 With editor 18 Dec 2024 First reviewer(s) invited 16 Jan 2025 Reviewer report(s) received 19 Jan 2025 Revision requested 21 Jan 2025 Revision received 29 Jan 2025 First reviewer(s) invited 31 Jan 2025 Reviewer report(s) received 07 Feb 2025 Submission accepted 13 Feb 2025, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=458e5258059, createdName=147f7447m93(暂无昵称), createdTime=Thu Feb 20 07:33:20 CST 2025, time=2025-02-20, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2232130, encodeId=3a1b22321306b, content=偏重的研究方向：肿瘤 经验分享：2024-03-19投稿 审稿意见已经显示返回，但就是不给反馈 这个杂志是最近是没人吗，编辑在干嘛啊啊，为什么这么慢，催稿邮件也不回复，想撤稿了。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d1875244065, createdName=147c8c2bm20(暂无昵称), createdTime=Mon Oct 21 14:02:34 CST 2024, time=2024-10-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2248365, encodeId=43642248365e4, content=审稿速度:4.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;生信 经验分享：5月投稿，7月with editor，期间一直邀请审稿人，11月两个审稿人接受邀请，12月审稿人提交意见，次日编辑给大修，给了14天，大修后3天接受。整体历时7个月，除了审稿人比较难找，编辑还是很有效率的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66e26515767, createdName=ms2000000771050051, createdTime=Thu Jan 16 17:59:37 CST 2025, time=2025-01-16, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2245126, encodeId=ad0b2245126e8, content=审稿速度:12.0 | 投稿命中率:75.0 经验分享：8个月了，还卡在第二个审稿人，我真是醉了。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91bb9295575, createdName=ms7000000026116265, createdTime=Fri Dec 27 10:42:00 CST 2024, time=2024-12-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2246927, encodeId=69b4224692e1d, content=妈的，2024年10月6号投的，到现在还是一直卡在审稿人邀请阶段，发了很多封咨询和催稿邮件都没得到任何回复，这个期刊究竟是怎么回事啊？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aeac6475076, createdName=ms1000000763838070, createdTime=Tue Jan 07 11:44:44 CST 2025, time=2025-01-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2242831, encodeId=4166224283167, content=偏重的研究方向：肿瘤;细胞生物学;生信 经验分享：With Editor2周了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65ab5425857, createdName=Doctorfan, createdTime=Mon Dec 16 10:52:12 CST 2024, time=2024-12-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2242971, encodeId=501e22429e1fe, content=为什么我的Research Square 那里这个杂志显示的是Draft呢?Research Square 里我投的其他杂志的文章标志都是Article, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1568789293, createdName=ms5000002019242226, createdTime=Mon Dec 16 19:32:14 CST 2024, time=2024-12-16, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2235847, encodeId=ccd9223584e59, content=偏重的研究方向：肿瘤;细胞生物学;Cancer 经验分享：发了邮件撤稿，都一周了编辑怎么还是不回复啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3868200180, createdName=ms1000001069261709, createdTime=Fri Nov 08 10:41:22 CST 2024, time=2024-11-08, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2207053, encodeId=7503220e05397, content=半年了，一点动静都没有，发邮件过去也没回复，什么情况啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEIX9OxibS9MeEepshV6P2nFfBwFyvFgJ2lrXAv18E1SwUCk5sZT1ZNfxwiaFCicIh4icVxLxez1qcWm0g/132, createdBy=fa5e2504185, createdName=ms8092613637533610, createdTime=Tue May 28 17:23:36 CST 2024, time=2024-05-28, status=1, ipAttribution=湖南省)]

2024-10-21 147c8c2bm20(暂无昵称) 来自江苏省

偏重的研究方向：肿瘤
经验分享：2024-03-19投稿
审稿意见已经显示返回，但就是不给反馈
这个杂志是最近是没人吗，编辑在干嘛啊啊，为什么这么慢，催稿邮件也不回复，想撤稿了。。。。

40 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2253179, encodeId=34e422531e9d0, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：2024年5月投稿，7月一审返回，二审一直找不到人，中间发了几封催稿信，到2025年1月二审返回，但杂志社始终没做决定，等了一个月又发了信件询问，第一个审稿人没有意见，建议发表，第二个审稿人表示需要加一些实验，编辑给了rejection，历时10个月，中间除了写信询问，完全不知道进度如何，建议比较急的谨慎投稿，还有长时间没消息的也最好撤稿，要不然很大概率白费几个月的时间。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91bb9295575, createdName=ms7000000026116265, createdTime=Sun Feb 23 16:28:33 CST 2025, time=2025-02-23, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2252747, encodeId=7a782252e47b1, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：投稿过程还算顺利，等待送外审稿等了一个月，供参考： Submission received 18 Dec 2024 With editor 18 Dec 2024 First reviewer(s) invited 16 Jan 2025 Reviewer report(s) received 19 Jan 2025 Revision requested 21 Jan 2025 Revision received 29 Jan 2025 First reviewer(s) invited 31 Jan 2025 Reviewer report(s) received 07 Feb 2025 Submission accepted 13 Feb 2025, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=458e5258059, createdName=147f7447m93(暂无昵称), createdTime=Thu Feb 20 07:33:20 CST 2025, time=2025-02-20, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2232130, encodeId=3a1b22321306b, content=偏重的研究方向：肿瘤 经验分享：2024-03-19投稿 审稿意见已经显示返回，但就是不给反馈 这个杂志是最近是没人吗，编辑在干嘛啊啊，为什么这么慢，催稿邮件也不回复，想撤稿了。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d1875244065, createdName=147c8c2bm20(暂无昵称), createdTime=Mon Oct 21 14:02:34 CST 2024, time=2024-10-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2248365, encodeId=43642248365e4, content=审稿速度:4.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;生信 经验分享：5月投稿，7月with editor，期间一直邀请审稿人，11月两个审稿人接受邀请，12月审稿人提交意见，次日编辑给大修，给了14天，大修后3天接受。整体历时7个月，除了审稿人比较难找，编辑还是很有效率的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66e26515767, createdName=ms2000000771050051, createdTime=Thu Jan 16 17:59:37 CST 2025, time=2025-01-16, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2245126, encodeId=ad0b2245126e8, content=审稿速度:12.0 | 投稿命中率:75.0 经验分享：8个月了，还卡在第二个审稿人，我真是醉了。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91bb9295575, createdName=ms7000000026116265, createdTime=Fri Dec 27 10:42:00 CST 2024, time=2024-12-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2246927, encodeId=69b4224692e1d, content=妈的，2024年10月6号投的，到现在还是一直卡在审稿人邀请阶段，发了很多封咨询和催稿邮件都没得到任何回复，这个期刊究竟是怎么回事啊？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aeac6475076, createdName=ms1000000763838070, createdTime=Tue Jan 07 11:44:44 CST 2025, time=2025-01-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2242831, encodeId=4166224283167, content=偏重的研究方向：肿瘤;细胞生物学;生信 经验分享：With Editor2周了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65ab5425857, createdName=Doctorfan, createdTime=Mon Dec 16 10:52:12 CST 2024, time=2024-12-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2242971, encodeId=501e22429e1fe, content=为什么我的Research Square 那里这个杂志显示的是Draft呢?Research Square 里我投的其他杂志的文章标志都是Article, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1568789293, createdName=ms5000002019242226, createdTime=Mon Dec 16 19:32:14 CST 2024, time=2024-12-16, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2235847, encodeId=ccd9223584e59, content=偏重的研究方向：肿瘤;细胞生物学;Cancer 经验分享：发了邮件撤稿，都一周了编辑怎么还是不回复啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3868200180, createdName=ms1000001069261709, createdTime=Fri Nov 08 10:41:22 CST 2024, time=2024-11-08, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2207053, encodeId=7503220e05397, content=半年了，一点动静都没有，发邮件过去也没回复，什么情况啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEIX9OxibS9MeEepshV6P2nFfBwFyvFgJ2lrXAv18E1SwUCk5sZT1ZNfxwiaFCicIh4icVxLxez1qcWm0g/132, createdBy=fa5e2504185, createdName=ms8092613637533610, createdTime=Tue May 28 17:23:36 CST 2024, time=2024-05-28, status=1, ipAttribution=湖南省)]

2025-01-16 ms2000000771050051 来自浙江省

审稿速度:4.0 | 投稿命中率:50.0
偏重的研究方向：肿瘤;生信
经验分享：5月投稿，7月with editor，期间一直邀请审稿人，11月两个审稿人接受邀请，12月审稿人提交意见，次日编辑给大修，给了14天，大修后3天接受。整体历时7个月，除了审稿人比较难找，编辑还是很有效率的。

15 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2253179, encodeId=34e422531e9d0, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：2024年5月投稿，7月一审返回，二审一直找不到人，中间发了几封催稿信，到2025年1月二审返回，但杂志社始终没做决定，等了一个月又发了信件询问，第一个审稿人没有意见，建议发表，第二个审稿人表示需要加一些实验，编辑给了rejection，历时10个月，中间除了写信询问，完全不知道进度如何，建议比较急的谨慎投稿，还有长时间没消息的也最好撤稿，要不然很大概率白费几个月的时间。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91bb9295575, createdName=ms7000000026116265, createdTime=Sun Feb 23 16:28:33 CST 2025, time=2025-02-23, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2252747, encodeId=7a782252e47b1, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：投稿过程还算顺利，等待送外审稿等了一个月，供参考： Submission received 18 Dec 2024 With editor 18 Dec 2024 First reviewer(s) invited 16 Jan 2025 Reviewer report(s) received 19 Jan 2025 Revision requested 21 Jan 2025 Revision received 29 Jan 2025 First reviewer(s) invited 31 Jan 2025 Reviewer report(s) received 07 Feb 2025 Submission accepted 13 Feb 2025, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=458e5258059, createdName=147f7447m93(暂无昵称), createdTime=Thu Feb 20 07:33:20 CST 2025, time=2025-02-20, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2232130, encodeId=3a1b22321306b, content=偏重的研究方向：肿瘤 经验分享：2024-03-19投稿 审稿意见已经显示返回，但就是不给反馈 这个杂志是最近是没人吗，编辑在干嘛啊啊，为什么这么慢，催稿邮件也不回复，想撤稿了。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d1875244065, createdName=147c8c2bm20(暂无昵称), createdTime=Mon Oct 21 14:02:34 CST 2024, time=2024-10-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2248365, encodeId=43642248365e4, content=审稿速度:4.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;生信 经验分享：5月投稿，7月with editor，期间一直邀请审稿人，11月两个审稿人接受邀请，12月审稿人提交意见，次日编辑给大修，给了14天，大修后3天接受。整体历时7个月，除了审稿人比较难找，编辑还是很有效率的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66e26515767, createdName=ms2000000771050051, createdTime=Thu Jan 16 17:59:37 CST 2025, time=2025-01-16, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2245126, encodeId=ad0b2245126e8, content=审稿速度:12.0 | 投稿命中率:75.0 经验分享：8个月了，还卡在第二个审稿人，我真是醉了。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91bb9295575, createdName=ms7000000026116265, createdTime=Fri Dec 27 10:42:00 CST 2024, time=2024-12-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2246927, encodeId=69b4224692e1d, content=妈的，2024年10月6号投的，到现在还是一直卡在审稿人邀请阶段，发了很多封咨询和催稿邮件都没得到任何回复，这个期刊究竟是怎么回事啊？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aeac6475076, createdName=ms1000000763838070, createdTime=Tue Jan 07 11:44:44 CST 2025, time=2025-01-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2242831, encodeId=4166224283167, content=偏重的研究方向：肿瘤;细胞生物学;生信 经验分享：With Editor2周了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65ab5425857, createdName=Doctorfan, createdTime=Mon Dec 16 10:52:12 CST 2024, time=2024-12-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2242971, encodeId=501e22429e1fe, content=为什么我的Research Square 那里这个杂志显示的是Draft呢?Research Square 里我投的其他杂志的文章标志都是Article, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1568789293, createdName=ms5000002019242226, createdTime=Mon Dec 16 19:32:14 CST 2024, time=2024-12-16, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2235847, encodeId=ccd9223584e59, content=偏重的研究方向：肿瘤;细胞生物学;Cancer 经验分享：发了邮件撤稿，都一周了编辑怎么还是不回复啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3868200180, createdName=ms1000001069261709, createdTime=Fri Nov 08 10:41:22 CST 2024, time=2024-11-08, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2207053, encodeId=7503220e05397, content=半年了，一点动静都没有，发邮件过去也没回复，什么情况啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEIX9OxibS9MeEepshV6P2nFfBwFyvFgJ2lrXAv18E1SwUCk5sZT1ZNfxwiaFCicIh4icVxLxez1qcWm0g/132, createdBy=fa5e2504185, createdName=ms8092613637533610, createdTime=Tue May 28 17:23:36 CST 2024, time=2024-05-28, status=1, ipAttribution=湖南省)]

2024-12-27 ms7000000026116265 来自上海

审稿速度:12.0 | 投稿命中率:75.0
经验分享：8个月了，还卡在第二个审稿人，我真是醉了。。。。

23 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2253179, encodeId=34e422531e9d0, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：2024年5月投稿，7月一审返回，二审一直找不到人，中间发了几封催稿信，到2025年1月二审返回，但杂志社始终没做决定，等了一个月又发了信件询问，第一个审稿人没有意见，建议发表，第二个审稿人表示需要加一些实验，编辑给了rejection，历时10个月，中间除了写信询问，完全不知道进度如何，建议比较急的谨慎投稿，还有长时间没消息的也最好撤稿，要不然很大概率白费几个月的时间。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91bb9295575, createdName=ms7000000026116265, createdTime=Sun Feb 23 16:28:33 CST 2025, time=2025-02-23, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2252747, encodeId=7a782252e47b1, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：投稿过程还算顺利，等待送外审稿等了一个月，供参考： Submission received 18 Dec 2024 With editor 18 Dec 2024 First reviewer(s) invited 16 Jan 2025 Reviewer report(s) received 19 Jan 2025 Revision requested 21 Jan 2025 Revision received 29 Jan 2025 First reviewer(s) invited 31 Jan 2025 Reviewer report(s) received 07 Feb 2025 Submission accepted 13 Feb 2025, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=458e5258059, createdName=147f7447m93(暂无昵称), createdTime=Thu Feb 20 07:33:20 CST 2025, time=2025-02-20, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2232130, encodeId=3a1b22321306b, content=偏重的研究方向：肿瘤 经验分享：2024-03-19投稿 审稿意见已经显示返回，但就是不给反馈 这个杂志是最近是没人吗，编辑在干嘛啊啊，为什么这么慢，催稿邮件也不回复，想撤稿了。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d1875244065, createdName=147c8c2bm20(暂无昵称), createdTime=Mon Oct 21 14:02:34 CST 2024, time=2024-10-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2248365, encodeId=43642248365e4, content=审稿速度:4.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;生信 经验分享：5月投稿，7月with editor，期间一直邀请审稿人，11月两个审稿人接受邀请，12月审稿人提交意见，次日编辑给大修，给了14天，大修后3天接受。整体历时7个月，除了审稿人比较难找，编辑还是很有效率的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66e26515767, createdName=ms2000000771050051, createdTime=Thu Jan 16 17:59:37 CST 2025, time=2025-01-16, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2245126, encodeId=ad0b2245126e8, content=审稿速度:12.0 | 投稿命中率:75.0 经验分享：8个月了，还卡在第二个审稿人，我真是醉了。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91bb9295575, createdName=ms7000000026116265, createdTime=Fri Dec 27 10:42:00 CST 2024, time=2024-12-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2246927, encodeId=69b4224692e1d, content=妈的，2024年10月6号投的，到现在还是一直卡在审稿人邀请阶段，发了很多封咨询和催稿邮件都没得到任何回复，这个期刊究竟是怎么回事啊？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aeac6475076, createdName=ms1000000763838070, createdTime=Tue Jan 07 11:44:44 CST 2025, time=2025-01-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2242831, encodeId=4166224283167, content=偏重的研究方向：肿瘤;细胞生物学;生信 经验分享：With Editor2周了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65ab5425857, createdName=Doctorfan, createdTime=Mon Dec 16 10:52:12 CST 2024, time=2024-12-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2242971, encodeId=501e22429e1fe, content=为什么我的Research Square 那里这个杂志显示的是Draft呢?Research Square 里我投的其他杂志的文章标志都是Article, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1568789293, createdName=ms5000002019242226, createdTime=Mon Dec 16 19:32:14 CST 2024, time=2024-12-16, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2235847, encodeId=ccd9223584e59, content=偏重的研究方向：肿瘤;细胞生物学;Cancer 经验分享：发了邮件撤稿，都一周了编辑怎么还是不回复啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3868200180, createdName=ms1000001069261709, createdTime=Fri Nov 08 10:41:22 CST 2024, time=2024-11-08, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2207053, encodeId=7503220e05397, content=半年了，一点动静都没有，发邮件过去也没回复，什么情况啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEIX9OxibS9MeEepshV6P2nFfBwFyvFgJ2lrXAv18E1SwUCk5sZT1ZNfxwiaFCicIh4icVxLxez1qcWm0g/132, createdBy=fa5e2504185, createdName=ms8092613637533610, createdTime=Tue May 28 17:23:36 CST 2024, time=2024-05-28, status=1, ipAttribution=湖南省)]

2025-01-07 ms1000000763838070 来自广东省

妈的，2024年10月6号投的，到现在还是一直卡在审稿人邀请阶段，发了很多封咨询和催稿邮件都没得到任何回复，这个期刊究竟是怎么回事啊？？？

52 0

[GetPortalCommentsPageByObjectIdResponse(id=2253179, encodeId=34e422531e9d0, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：2024年5月投稿，7月一审返回，二审一直找不到人，中间发了几封催稿信，到2025年1月二审返回，但杂志社始终没做决定，等了一个月又发了信件询问，第一个审稿人没有意见，建议发表，第二个审稿人表示需要加一些实验，编辑给了rejection，历时10个月，中间除了写信询问，完全不知道进度如何，建议比较急的谨慎投稿，还有长时间没消息的也最好撤稿，要不然很大概率白费几个月的时间。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91bb9295575, createdName=ms7000000026116265, createdTime=Sun Feb 23 16:28:33 CST 2025, time=2025-02-23, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2252747, encodeId=7a782252e47b1, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：投稿过程还算顺利，等待送外审稿等了一个月，供参考： Submission received 18 Dec 2024 With editor 18 Dec 2024 First reviewer(s) invited 16 Jan 2025 Reviewer report(s) received 19 Jan 2025 Revision requested 21 Jan 2025 Revision received 29 Jan 2025 First reviewer(s) invited 31 Jan 2025 Reviewer report(s) received 07 Feb 2025 Submission accepted 13 Feb 2025, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=458e5258059, createdName=147f7447m93(暂无昵称), createdTime=Thu Feb 20 07:33:20 CST 2025, time=2025-02-20, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2232130, encodeId=3a1b22321306b, content=偏重的研究方向：肿瘤 经验分享：2024-03-19投稿 审稿意见已经显示返回，但就是不给反馈 这个杂志是最近是没人吗，编辑在干嘛啊啊，为什么这么慢，催稿邮件也不回复，想撤稿了。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d1875244065, createdName=147c8c2bm20(暂无昵称), createdTime=Mon Oct 21 14:02:34 CST 2024, time=2024-10-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2248365, encodeId=43642248365e4, content=审稿速度:4.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;生信 经验分享：5月投稿，7月with editor，期间一直邀请审稿人，11月两个审稿人接受邀请，12月审稿人提交意见，次日编辑给大修，给了14天，大修后3天接受。整体历时7个月，除了审稿人比较难找，编辑还是很有效率的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66e26515767, createdName=ms2000000771050051, createdTime=Thu Jan 16 17:59:37 CST 2025, time=2025-01-16, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2245126, encodeId=ad0b2245126e8, content=审稿速度:12.0 | 投稿命中率:75.0 经验分享：8个月了，还卡在第二个审稿人，我真是醉了。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91bb9295575, createdName=ms7000000026116265, createdTime=Fri Dec 27 10:42:00 CST 2024, time=2024-12-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2246927, encodeId=69b4224692e1d, content=妈的，2024年10月6号投的，到现在还是一直卡在审稿人邀请阶段，发了很多封咨询和催稿邮件都没得到任何回复，这个期刊究竟是怎么回事啊？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aeac6475076, createdName=ms1000000763838070, createdTime=Tue Jan 07 11:44:44 CST 2025, time=2025-01-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2242831, encodeId=4166224283167, content=偏重的研究方向：肿瘤;细胞生物学;生信 经验分享：With Editor2周了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65ab5425857, createdName=Doctorfan, createdTime=Mon Dec 16 10:52:12 CST 2024, time=2024-12-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2242971, encodeId=501e22429e1fe, content=为什么我的Research Square 那里这个杂志显示的是Draft呢?Research Square 里我投的其他杂志的文章标志都是Article, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1568789293, createdName=ms5000002019242226, createdTime=Mon Dec 16 19:32:14 CST 2024, time=2024-12-16, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2235847, encodeId=ccd9223584e59, content=偏重的研究方向：肿瘤;细胞生物学;Cancer 经验分享：发了邮件撤稿，都一周了编辑怎么还是不回复啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3868200180, createdName=ms1000001069261709, createdTime=Fri Nov 08 10:41:22 CST 2024, time=2024-11-08, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2207053, encodeId=7503220e05397, content=半年了，一点动静都没有，发邮件过去也没回复，什么情况啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEIX9OxibS9MeEepshV6P2nFfBwFyvFgJ2lrXAv18E1SwUCk5sZT1ZNfxwiaFCicIh4icVxLxez1qcWm0g/132, createdBy=fa5e2504185, createdName=ms8092613637533610, createdTime=Tue May 28 17:23:36 CST 2024, time=2024-05-28, status=1, ipAttribution=湖南省)]

2024-12-16 Doctorfan 来自上海

偏重的研究方向：肿瘤;细胞生物学;生信
经验分享：With Editor2周了

0 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2253179, encodeId=34e422531e9d0, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：2024年5月投稿，7月一审返回，二审一直找不到人，中间发了几封催稿信，到2025年1月二审返回，但杂志社始终没做决定，等了一个月又发了信件询问，第一个审稿人没有意见，建议发表，第二个审稿人表示需要加一些实验，编辑给了rejection，历时10个月，中间除了写信询问，完全不知道进度如何，建议比较急的谨慎投稿，还有长时间没消息的也最好撤稿，要不然很大概率白费几个月的时间。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91bb9295575, createdName=ms7000000026116265, createdTime=Sun Feb 23 16:28:33 CST 2025, time=2025-02-23, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2252747, encodeId=7a782252e47b1, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：投稿过程还算顺利，等待送外审稿等了一个月，供参考： Submission received 18 Dec 2024 With editor 18 Dec 2024 First reviewer(s) invited 16 Jan 2025 Reviewer report(s) received 19 Jan 2025 Revision requested 21 Jan 2025 Revision received 29 Jan 2025 First reviewer(s) invited 31 Jan 2025 Reviewer report(s) received 07 Feb 2025 Submission accepted 13 Feb 2025, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=458e5258059, createdName=147f7447m93(暂无昵称), createdTime=Thu Feb 20 07:33:20 CST 2025, time=2025-02-20, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2232130, encodeId=3a1b22321306b, content=偏重的研究方向：肿瘤 经验分享：2024-03-19投稿 审稿意见已经显示返回，但就是不给反馈 这个杂志是最近是没人吗，编辑在干嘛啊啊，为什么这么慢，催稿邮件也不回复，想撤稿了。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d1875244065, createdName=147c8c2bm20(暂无昵称), createdTime=Mon Oct 21 14:02:34 CST 2024, time=2024-10-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2248365, encodeId=43642248365e4, content=审稿速度:4.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;生信 经验分享：5月投稿，7月with editor，期间一直邀请审稿人，11月两个审稿人接受邀请，12月审稿人提交意见，次日编辑给大修，给了14天，大修后3天接受。整体历时7个月，除了审稿人比较难找，编辑还是很有效率的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66e26515767, createdName=ms2000000771050051, createdTime=Thu Jan 16 17:59:37 CST 2025, time=2025-01-16, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2245126, encodeId=ad0b2245126e8, content=审稿速度:12.0 | 投稿命中率:75.0 经验分享：8个月了，还卡在第二个审稿人，我真是醉了。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91bb9295575, createdName=ms7000000026116265, createdTime=Fri Dec 27 10:42:00 CST 2024, time=2024-12-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2246927, encodeId=69b4224692e1d, content=妈的，2024年10月6号投的，到现在还是一直卡在审稿人邀请阶段，发了很多封咨询和催稿邮件都没得到任何回复，这个期刊究竟是怎么回事啊？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aeac6475076, createdName=ms1000000763838070, createdTime=Tue Jan 07 11:44:44 CST 2025, time=2025-01-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2242831, encodeId=4166224283167, content=偏重的研究方向：肿瘤;细胞生物学;生信 经验分享：With Editor2周了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65ab5425857, createdName=Doctorfan, createdTime=Mon Dec 16 10:52:12 CST 2024, time=2024-12-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2242971, encodeId=501e22429e1fe, content=为什么我的Research Square 那里这个杂志显示的是Draft呢?Research Square 里我投的其他杂志的文章标志都是Article, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1568789293, createdName=ms5000002019242226, createdTime=Mon Dec 16 19:32:14 CST 2024, time=2024-12-16, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2235847, encodeId=ccd9223584e59, content=偏重的研究方向：肿瘤;细胞生物学;Cancer 经验分享：发了邮件撤稿，都一周了编辑怎么还是不回复啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3868200180, createdName=ms1000001069261709, createdTime=Fri Nov 08 10:41:22 CST 2024, time=2024-11-08, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2207053, encodeId=7503220e05397, content=半年了，一点动静都没有，发邮件过去也没回复，什么情况啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEIX9OxibS9MeEepshV6P2nFfBwFyvFgJ2lrXAv18E1SwUCk5sZT1ZNfxwiaFCicIh4icVxLxez1qcWm0g/132, createdBy=fa5e2504185, createdName=ms8092613637533610, createdTime=Tue May 28 17:23:36 CST 2024, time=2024-05-28, status=1, ipAttribution=湖南省)]

2024-12-16 ms5000002019242226 来自江苏省

为什么我的Research Square 那里这个杂志显示的是Draft呢?Research Square 里我投的其他杂志的文章标志都是Article

18 0

[GetPortalCommentsPageByObjectIdResponse(id=2253179, encodeId=34e422531e9d0, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：2024年5月投稿，7月一审返回，二审一直找不到人，中间发了几封催稿信，到2025年1月二审返回，但杂志社始终没做决定，等了一个月又发了信件询问，第一个审稿人没有意见，建议发表，第二个审稿人表示需要加一些实验，编辑给了rejection，历时10个月，中间除了写信询问，完全不知道进度如何，建议比较急的谨慎投稿，还有长时间没消息的也最好撤稿，要不然很大概率白费几个月的时间。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91bb9295575, createdName=ms7000000026116265, createdTime=Sun Feb 23 16:28:33 CST 2025, time=2025-02-23, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2252747, encodeId=7a782252e47b1, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：投稿过程还算顺利，等待送外审稿等了一个月，供参考： Submission received 18 Dec 2024 With editor 18 Dec 2024 First reviewer(s) invited 16 Jan 2025 Reviewer report(s) received 19 Jan 2025 Revision requested 21 Jan 2025 Revision received 29 Jan 2025 First reviewer(s) invited 31 Jan 2025 Reviewer report(s) received 07 Feb 2025 Submission accepted 13 Feb 2025, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=458e5258059, createdName=147f7447m93(暂无昵称), createdTime=Thu Feb 20 07:33:20 CST 2025, time=2025-02-20, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2232130, encodeId=3a1b22321306b, content=偏重的研究方向：肿瘤 经验分享：2024-03-19投稿 审稿意见已经显示返回，但就是不给反馈 这个杂志是最近是没人吗，编辑在干嘛啊啊，为什么这么慢，催稿邮件也不回复，想撤稿了。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d1875244065, createdName=147c8c2bm20(暂无昵称), createdTime=Mon Oct 21 14:02:34 CST 2024, time=2024-10-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2248365, encodeId=43642248365e4, content=审稿速度:4.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;生信 经验分享：5月投稿，7月with editor，期间一直邀请审稿人，11月两个审稿人接受邀请，12月审稿人提交意见，次日编辑给大修，给了14天，大修后3天接受。整体历时7个月，除了审稿人比较难找，编辑还是很有效率的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66e26515767, createdName=ms2000000771050051, createdTime=Thu Jan 16 17:59:37 CST 2025, time=2025-01-16, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2245126, encodeId=ad0b2245126e8, content=审稿速度:12.0 | 投稿命中率:75.0 经验分享：8个月了，还卡在第二个审稿人，我真是醉了。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91bb9295575, createdName=ms7000000026116265, createdTime=Fri Dec 27 10:42:00 CST 2024, time=2024-12-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2246927, encodeId=69b4224692e1d, content=妈的，2024年10月6号投的，到现在还是一直卡在审稿人邀请阶段，发了很多封咨询和催稿邮件都没得到任何回复，这个期刊究竟是怎么回事啊？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aeac6475076, createdName=ms1000000763838070, createdTime=Tue Jan 07 11:44:44 CST 2025, time=2025-01-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2242831, encodeId=4166224283167, content=偏重的研究方向：肿瘤;细胞生物学;生信 经验分享：With Editor2周了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65ab5425857, createdName=Doctorfan, createdTime=Mon Dec 16 10:52:12 CST 2024, time=2024-12-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2242971, encodeId=501e22429e1fe, content=为什么我的Research Square 那里这个杂志显示的是Draft呢?Research Square 里我投的其他杂志的文章标志都是Article, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1568789293, createdName=ms5000002019242226, createdTime=Mon Dec 16 19:32:14 CST 2024, time=2024-12-16, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2235847, encodeId=ccd9223584e59, content=偏重的研究方向：肿瘤;细胞生物学;Cancer 经验分享：发了邮件撤稿，都一周了编辑怎么还是不回复啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3868200180, createdName=ms1000001069261709, createdTime=Fri Nov 08 10:41:22 CST 2024, time=2024-11-08, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2207053, encodeId=7503220e05397, content=半年了，一点动静都没有，发邮件过去也没回复，什么情况啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEIX9OxibS9MeEepshV6P2nFfBwFyvFgJ2lrXAv18E1SwUCk5sZT1ZNfxwiaFCicIh4icVxLxez1qcWm0g/132, createdBy=fa5e2504185, createdName=ms8092613637533610, createdTime=Tue May 28 17:23:36 CST 2024, time=2024-05-28, status=1, ipAttribution=湖南省)]

2024-11-08 ms1000001069261709 来自湖北省

偏重的研究方向：肿瘤;细胞生物学;Cancer
经验分享：发了邮件撤稿，都一周了编辑怎么还是不回复啊

31 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2253179, encodeId=34e422531e9d0, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：2024年5月投稿，7月一审返回，二审一直找不到人，中间发了几封催稿信，到2025年1月二审返回，但杂志社始终没做决定，等了一个月又发了信件询问，第一个审稿人没有意见，建议发表，第二个审稿人表示需要加一些实验，编辑给了rejection，历时10个月，中间除了写信询问，完全不知道进度如何，建议比较急的谨慎投稿，还有长时间没消息的也最好撤稿，要不然很大概率白费几个月的时间。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91bb9295575, createdName=ms7000000026116265, createdTime=Sun Feb 23 16:28:33 CST 2025, time=2025-02-23, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2252747, encodeId=7a782252e47b1, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：投稿过程还算顺利，等待送外审稿等了一个月，供参考： Submission received 18 Dec 2024 With editor 18 Dec 2024 First reviewer(s) invited 16 Jan 2025 Reviewer report(s) received 19 Jan 2025 Revision requested 21 Jan 2025 Revision received 29 Jan 2025 First reviewer(s) invited 31 Jan 2025 Reviewer report(s) received 07 Feb 2025 Submission accepted 13 Feb 2025, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=458e5258059, createdName=147f7447m93(暂无昵称), createdTime=Thu Feb 20 07:33:20 CST 2025, time=2025-02-20, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2232130, encodeId=3a1b22321306b, content=偏重的研究方向：肿瘤 经验分享：2024-03-19投稿 审稿意见已经显示返回，但就是不给反馈 这个杂志是最近是没人吗，编辑在干嘛啊啊，为什么这么慢，催稿邮件也不回复，想撤稿了。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d1875244065, createdName=147c8c2bm20(暂无昵称), createdTime=Mon Oct 21 14:02:34 CST 2024, time=2024-10-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2248365, encodeId=43642248365e4, content=审稿速度:4.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;生信 经验分享：5月投稿，7月with editor，期间一直邀请审稿人，11月两个审稿人接受邀请，12月审稿人提交意见，次日编辑给大修，给了14天，大修后3天接受。整体历时7个月，除了审稿人比较难找，编辑还是很有效率的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66e26515767, createdName=ms2000000771050051, createdTime=Thu Jan 16 17:59:37 CST 2025, time=2025-01-16, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2245126, encodeId=ad0b2245126e8, content=审稿速度:12.0 | 投稿命中率:75.0 经验分享：8个月了，还卡在第二个审稿人，我真是醉了。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91bb9295575, createdName=ms7000000026116265, createdTime=Fri Dec 27 10:42:00 CST 2024, time=2024-12-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2246927, encodeId=69b4224692e1d, content=妈的，2024年10月6号投的，到现在还是一直卡在审稿人邀请阶段，发了很多封咨询和催稿邮件都没得到任何回复，这个期刊究竟是怎么回事啊？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aeac6475076, createdName=ms1000000763838070, createdTime=Tue Jan 07 11:44:44 CST 2025, time=2025-01-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2242831, encodeId=4166224283167, content=偏重的研究方向：肿瘤;细胞生物学;生信 经验分享：With Editor2周了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65ab5425857, createdName=Doctorfan, createdTime=Mon Dec 16 10:52:12 CST 2024, time=2024-12-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2242971, encodeId=501e22429e1fe, content=为什么我的Research Square 那里这个杂志显示的是Draft呢?Research Square 里我投的其他杂志的文章标志都是Article, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1568789293, createdName=ms5000002019242226, createdTime=Mon Dec 16 19:32:14 CST 2024, time=2024-12-16, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2235847, encodeId=ccd9223584e59, content=偏重的研究方向：肿瘤;细胞生物学;Cancer 经验分享：发了邮件撤稿，都一周了编辑怎么还是不回复啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3868200180, createdName=ms1000001069261709, createdTime=Fri Nov 08 10:41:22 CST 2024, time=2024-11-08, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2207053, encodeId=7503220e05397, content=半年了，一点动静都没有，发邮件过去也没回复，什么情况啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEIX9OxibS9MeEepshV6P2nFfBwFyvFgJ2lrXAv18E1SwUCk5sZT1ZNfxwiaFCicIh4icVxLxez1qcWm0g/132, createdBy=fa5e2504185, createdName=ms8092613637533610, createdTime=Tue May 28 17:23:36 CST 2024, time=2024-05-28, status=1, ipAttribution=湖南省)]

2024-05-28 ms8092613637533610 来自湖南省

半年了，一点动静都没有，发邮件过去也没回复，什么情况啊？

102 8

展开8条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务